Source: Drug Discovery and Development Novo Nordisk confirmed in their reporting that more than 4 million patients around the world are using GLP-1 drugs for obesity treatment
While the compounded versions themselves are not FDA-approved, the pharmacies that make them must follow strict safety and quality standards
The pivotal trials measured outcomes primarily through the scale and cardiometabolic markers
Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set
Kuffner K, Triebelhorn J, Meindl K, Benner C, Manook A, Sudria-Lopez D, et al
As such, we have a more recent article on this topic: Who Needs Digestive Enzymes